Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
about
Hydrogen Sulfide in Physiology and Diseases of the Digestive TractCXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factorBuilding a better aspirin: gaseous solutions to a century-old problemThe gastroprotective effect of ethyl acetate fraction of hot water extract of Trichosanthes cucumerina Linn and its underlying mechanisms.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberiana roots bark extract as an anti-ulcerogenic agent.Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs.Muc-2-deficient mice display a sex-specific, COX-2-related impairment of gastric mucosal repair.The role of PGE2 in intestinal inflammation and tumorigenesis.Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.Ulcer healing and mechanism(s) of action involved in the gastroprotective activity of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus.Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory painCyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells.Clinical relevance of aberrant polypoid nodule scar after endoscopic submucosal dissection.NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategiesMechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Pathogenesis of neonatal necrotizing enterocolitis.Epithelial MUC1 promotes cell migration, reduces apoptosis and affects levels of mucosal modulators during acetylsalicylic acid (aspirin)-induced gastropathy.Ghrelin Protection against Cytotoxic Effect of Ethanol on Rat Salivary Mucin Synthesis involves Cytosolic Phospholipase A2 Activation through S-Nitrosylation.Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talkGastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1.In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells.Mechanism of Cytosolic Phospholipase A(2) Activation in Ghrelin Protection of Salivary Gland Acinar Cells against Ethanol Cytotoxicity.Role of cyclooxygenase-2 in intestinal injury in neonatal ratsGastric Ulcers in Middle-Aged Rats: The Healing Effect of Essential Oil from Citrus aurantium L. (Rutaceae).Gastroprotective Effect of Hydroalcoholic Extract of Aloe buettneri.Nitric oxide involved in the IL-1β-induced inhibition of fructose intestinal transport.Non-steroidal anti-inflammatory drug-induced enteropathy.Sphingosine-1-phosphate enhances IL-1{beta}-induced COX-2 expression in mouse intestinal subepithelial myofibroblasts.Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited.Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects.Polypoid nodule scar after gastric endoscopic submucosal dissection: results from a multicenter study
P2860
Q28087344-F3A6EFEB-58D7-432F-A6BC-9AA6CD9E94C5Q28116204-41F536A2-E215-4695-8F71-7FEE52736EBEQ28218664-765A3607-B2F3-4D7C-A0AC-C828557845F5Q33802426-BDE12571-E97F-417F-AE30-B9B06371EAB9Q34245387-FAD35712-7542-482F-8757-17FA3EB4C14FQ34274682-57A6C4D6-7CC5-4A7C-9DA7-B52AA11E8221Q34743086-BDD8F021-C97B-4BCB-A2A0-4844A96E206AQ34756209-13A3EA9B-1004-4B73-8CB1-34052C27EF7DQ35269711-1BAFC2A1-1F9A-475C-9819-C3699D187F22Q35523910-54FB7541-320E-4777-8D10-657A542702D0Q35825245-704AB222-B4E6-4623-850D-3C21F94E70C3Q35847266-C7EA3297-278A-41DD-A9FC-CBDFEDD2C8F0Q36378519-664EB1D8-A263-48C0-BBE9-AA0096CA9776Q36733684-6E64577D-21C1-4419-8D88-91281A81F0FFQ37263135-EC462D7F-F379-4AED-AFD1-2700F83F681CQ37882741-429277E5-1BF9-4467-BB2A-EAEF5F4B1293Q38097424-77D99527-A561-439A-81B8-0E47D6EE3676Q38260626-25ED7375-B483-4F29-83DB-A7F827F0D22CQ38411973-0BC8750F-7616-410F-A268-FE3FE28149DEQ38941294-873326A6-7E3F-4644-B17B-31BC0711AEB7Q39528512-2653096C-34CF-4023-9794-5B22409D37D5Q39561283-A0F30917-87AF-4210-8DF6-844865CAE68EQ39906230-41726080-5970-4678-806E-7F6AE44BDC13Q40328090-FD26D6DB-1AC8-4D5A-AFA3-7D37CF06D0D0Q41666492-8B0881AC-43A7-41A7-9931-9EA390367104Q42255955-30CE89E2-F206-4612-B017-E632364D30DCQ42404375-9B76C2AF-A31A-4312-ABC1-39E51D3F3918Q42781861-3A30F525-E440-431A-B475-AB22825C38D6Q42922629-FEDAA02F-DD07-4BA2-997E-25564B0B0CFDQ45400230-A78B8757-3D11-4FAC-AE3E-C00FBB6DCC94Q46429130-E999D926-EA7E-426F-8F74-651FBFE409FAQ47372560-1A5A92AB-9E5D-4869-90BB-9EF1A77F46DDQ54338296-D3C7378B-B10B-413C-8615-59CE8425EF7FQ57296566-5B06229F-D2A5-4010-9656-231CBF0B8601
P2860
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@ast
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@en
type
label
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@ast
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@en
prefLabel
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@ast
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@en
P2860
P356
P1476
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
@en
P2093
John L Wallace
Pallavi R Devchand
P2860
P304
P356
10.1038/SJ.BJP.0706201
P407
P577
2005-06-01T00:00:00Z